Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Cheng, Gang, Zielonka, Jacek, Hardy, Micael, Ouari, Olivier, Chitambar, Christopher R., Dwinell, Michael B., Kalyanaraman, Balaraman
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544408/
https://ncbi.nlm.nih.gov/pubmed/31191823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados